Reuters reported late Thursday afternoon that DepoMed Inc. (DEPO) is making preparations to put itself up for sale. The company is reportedly waiting for a court clarification on the patent exclusivity of its Nucynta drug before exploring a sale.
from RTT - Before the Bell http://ift.tt/2dd6Y3D
via IFTTT
No comments:
Post a Comment